Gerald said the 2015 market for Lympro was 150 million, of which we would capture a "significant portion." (15 million? 30 million? 50 million?)

The lone AMBS analyst, Jason Napodano, said his Lympro revenue estimate for 2015 was 1 million. And, his 2016 estimate was 3.5 million.

Gerald must put to bed the concern caused by these two contradictory estimates.....ASAP!